Does VILDAGLIPTIN Cause Disseminated intravascular coagulation? 11 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 11 reports of Disseminated intravascular coagulation have been filed in association with VILDAGLIPTIN. This represents 0.5% of all adverse event reports for VILDAGLIPTIN.
11
Reports of Disseminated intravascular coagulation with VILDAGLIPTIN
0.5%
of all VILDAGLIPTIN reports
1
Deaths
11
Hospitalizations
How Dangerous Is Disseminated intravascular coagulation From VILDAGLIPTIN?
Of the 11 reports, 1 (9.1%) resulted in death, 11 (100.0%) required hospitalization, and 4 (36.4%) were considered life-threatening.
Is Disseminated intravascular coagulation Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for VILDAGLIPTIN. However, 11 reports have been filed with the FAERS database.
What Other Side Effects Does VILDAGLIPTIN Cause?
Pemphigoid (495)
Hypoglycaemia (121)
Acute kidney injury (120)
Blood glucose increased (98)
Lactic acidosis (98)
Malaise (87)
Dyspnoea (84)
Drug ineffective (82)
Vomiting (72)
Diabetes mellitus (69)
What Other Drugs Cause Disseminated intravascular coagulation?
PREDNISOLONE (362)
METHOTREXATE (347)
DEXAMETHASONE (323)
METHYLPREDNISOLONE (307)
NIVOLUMAB (305)
CYCLOPHOSPHAMIDE (286)
TACROLIMUS (278)
PREDNISONE (277)
VINCRISTINE (245)
OXALIPLATIN (231)
Which VILDAGLIPTIN Alternatives Have Lower Disseminated intravascular coagulation Risk?
VILDAGLIPTIN vs VILOXAZINE
VILDAGLIPTIN vs VIMPAT
VILDAGLIPTIN vs VIMSELTINIB
VILDAGLIPTIN vs VINBLASTINE
VILDAGLIPTIN vs VINCRISTINE